Immunophotonics, Inc.
St. Louis, MO ยท Pharmaceuticals
Immunophotonics, Inc. is a pharmaceuticals company based in St. Louis, Missouri. In a Form D filed with the SEC on September 4, 2026, it reported raising $10,147,612 from 45 investors as part of an offering of indefinite size. The first sale in the offering took place on July 14, 2025.
- Amount raised
- $10,147,612
- Offering size
- Indefinite
- Investors so far
- 45
- Minimum investment
- $100,000
- First sale
- July 14, 2025
- Securities offered
- Equity
- Exemption claimed
- Rule 506(b)
- Industry
- Pharmaceuticals
- Headquarters
- St. Louis, Missouri
- Incorporated
- Delaware
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $10,147,612 | Indefinite | 45 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Other health care raises in Missouri
| Company | Location | Sector | Raised | Target | Filed |
|---|---|---|---|---|---|
| Charlestowne Senior Village LLC | Cottleville, MO | Health Care | $6.2M | $6.2M |